CALSADA CRISPINA - Insider Non-Derivative Transactions at Regulus Therapeutics Inc. (RGLS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 25, 2025, CALSADA CRISPINA's relationship to Regulus Therapeutics Inc. (RGLS) is Officer (Chief Financial Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RGLS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

CALSADA CRISPINA - Insider Non-Derivative Transactions of RGLS Common Stock

CALSADA CRISPINA - Insider Non-Derivative Transactions at RGLS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 26, 2025	Disposition -- (Common Stock)	140228	0	0
Jan 15, 2025	Sell -- (Common Stock)	5088	1.26	45478
Jan 14, 2025	Sell -- (Common Stock)	38716	1.26	50566
Jan 10, 2025	Acquisition -- (Common Stock)	62500	1.36	68282
Jan 10, 2025	Acquisition -- (Common Stock)	21000	1.3	89282
Jan 19, 2024	Sell -- (Common Stock)	5468	1.19	5782
Jan 13, 2024	Acquisition -- (Common Stock)	11250	0	11250